跳至主要内容
临床试验/NL-OMON20836
NL-OMON20836招募中不适用

Intensive molecular and electropathological characterization of patientS undergOing atriaL fibrillATion ablatION: a multicenter prospective cohort study

Academisch ziekenhuis Maastricht (azM)0 个研究点目标入组 500 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • In order to be eligible to participate in this registry, a subject must meet all of the following criteria:
  • · 18 years of age or older;
  • · Documented atrial fibrillation;
  • · Scheduled for AF ablation or redo AF ablation;
  • · Able and willing to provide written informed consent.

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this registry:
  • · Serious patient condition before ablation;
  • · Physically or mentally unable to provide written informed consent.
  • A subject who meets any of the following criteria will be excluded from the subset in whom additional consent for transesophageal ECG (TE-ECG) is asked:
  • · Known esophageal disease;
  • · Previous surgery on esophagus, throat or stomach;
  • · Recent (<4 weeks) myocardial infarction;
  • · Unwilling to provide additional informed consent.

研究者

发起方
Academisch ziekenhuis Maastricht (azM)

相似试验